Simulations Plus (SLP) and University of Connecticut Announce FDA Contract to Accelerate Development of Long-Acting Injectable Products
Go back to Simulations Plus (SLP) and University of Connecticut Announce FDA Contract to Accelerate Development of Long-Acting Injectable Products| SIMULATIONS PLUS, Inc. (NASDAQ: SLP) | Delayed: 18.41 -0.02 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.43 | 52 Week High | $11.89 | |||
| Open | $18.45 | 52 Week Low | $6.74 | |||
| Day High | $18.45 | P/E | 102.28 | |||
| Day Low | $18.41 | EPS | $0.18 | |||
| Volume | 232,126 | |||||
